Skip to content

RADX

Radiopharm Theranostics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$0.85
−4.13%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-69.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 27, 2026Voliotis Dimitris · officer: Chief Medical OfficerA-Award10,295,667$0.02
Oct 27, 2026Voliotis Dimitris · officer: Chief Medical OfficerA-Award10,295,666$0.02
Institutional positioning

13F filings over the trailing two quarters

New 1Increased 4Reduced 3Sold out 2
FilerActionSharesFiled
STONEPINE CAPITAL MANAGEMENT, LLCUnchanged51,000,000May 14, 2026
Stonepine Capital Management, LLCUnchanged51,000,000Aug 17, 2026
SILVERARC CAPITAL MANAGEMENT, LLCUnchanged187,406May 14, 2026
HSBC HOLDINGS PLCIncreased62,188Aug 14, 2026
REGAL PARTNERS LTDReduced40,138May 15, 2026
Regal Partners LtdUnchanged40,138Aug 14, 2026
PNC FINANCIAL SERVICES GROUP, INC.Increased20,000Aug 7, 2026
PNC FINANCIAL SERVICES GROUP, INC.Unchanged16,000May 8, 2026
UBS GROUP AGReduced3,000May 5, 2026
UBS Group AGReduced1,507Aug 13, 2026
Integrated Wealth Concepts LLCNew Position1,310Aug 12, 2026
RHUMBLINE ADVISERSIncreased195Aug 12, 2026
RHUMBLINE ADVISERSIncreased121May 12, 2026
STRATEGIC WEALTH PARTNERS, LTD.Sold Out0May 12, 2026
SILVERARC CAPITAL MANAGEMENT, LLCSold Out0May 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 27, 2026